The Elephant and the Needle

Investor Steve Eisman has his eye on a potentially explosive short-term trade in homebuilder stocks, thanks to President Donald Trump's proposal to buy $200 billion in mortgage-backed securities. The goal is simple: push down mortgage rates and get the housing market moving again. Whether it actually solves housing's bigger problems? That's another story.

Speaking on the Real Eisman Playbook podcast last week, Eisman pointed to Trump's plan as a catalyst that could send homebuilders on a rally, even after they already jumped on Friday. "Yes, they all rallied on Friday, but they could have more to go," he said.

The two names he's watching closely are Lennar Corp. (LEN) and D.R. Horton Inc. (DHI). Both stocks took a beating in 2025 but are starting to climb back as mortgage rates fall and valuations look increasingly attractive.

Mortgage Rates and the Math That Matters

"Mortgage rates are now down to 6%," Eisman noted, adding that "if they can get down to 5 and a half, my guess is that existing home sales will improve and new home sales will too."

Here's where it gets interesting. These aren't massive companies by market cap standards. D.R. Horton is the biggest at $45 billion. That relatively small size means that when money starts flowing into the sector, the stocks can move quickly and dramatically. "The stocks will go up more and faster than you might think," Eisman said, comparing the dynamic to "threading an elephant through a needle."

It's a vivid metaphor for what happens when big capital flows try to squeeze through small market caps. The result? Outsized price movements, at least in the short term.

The Problem That Won't Go Away

But Eisman was quick to temper expectations about what Trump's proposal can actually accomplish structurally. The plan might goose stock prices and even stimulate some buying activity, but it won't fix the real bottleneck choking the housing market: supply constraints.

Those problems, Eisman explained, are "all at the local level," with regulations making it difficult and expensive to build smaller homes. In other words, you can lower mortgage rates all you want, but if there aren't enough houses being built because of zoning laws, permitting nightmares, and local red tape, you're treating symptoms, not the disease.

From Slump to Surge

After a rough 2025 marked by high rates, tariff concerns, and aggressive immigration enforcement that rattled construction labor markets, homebuilder stocks are finding their footing in 2026. Policy momentum is shifting in the sector's favor, and the numbers are starting to reflect that.

Lennar has reversed its 16% decline from last year with a nearly 14% gain so far in 2026. D.R. Horton is up over 7%. The iShares US Home Construction ETF (ITB), which tracks the broader sector, has climbed 10.70% year-to-date after losing ground in 2025.

It's worth noting that ITB scores poorly on momentum metrics but shows favorable price trends across short, medium, and long-term horizons. Translation: the sector might not have the strongest technical tailwinds right now, but the direction is clearly upward.

Whether this momentum can hold depends on whether mortgage rates actually fall to Eisman's 5.5% target and whether buyers who've been sitting on the sidelines finally decide to jump in. If they do, threading that elephant through the needle might turn out to be easier than it sounds.